Related Experiment Video
Updated: Sep 19, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Machine Learning for Predicting the Transition From Gestational Diabetes to Type 2 Diabetes: A Systematic Review
Nisrin Magboul Elfadel Magboul1, Nagla Osman Mohamed Dkeen1, Hiba Abdelraouf Hyder Mohammed2
1Obstetrics and Gynecology, Najran Armed Forces Hospital, Ministry of Defense Health Services, Najran, SAU.
None:
Gestational diabetes mellitus (GDM) significantly increases the risk of developing type 2 diabetes (T2D) postpartum. Early identification of high-risk women using machine learning (ML) models could enable targeted interventions and improve outcomes. This systematic review aims to evaluate the performance, predictive features, and methodological quality of ML models designed to predict the transition from GDM to T2D. A comprehensive search was conducted across PubMed, Scopus, IEEE Xplore, and Web of Science, yielding 178 records. After removing duplicates and screening for eligibility, 13 studies were included. Data on study characteristics, ML algorithms, predictive features, model performance, and validation methods were extracted. Risk of bias was assessed using the PROBAST (Prediction model Risk of Bias Assessment Tool). The included studies demonstrated variable performance, with area under the curve (AUC) values ranging from 0.72 to 0.92. Models incorporating omics data outperformed clinical-only models. Key predictive features included age, b ody m ass i ndex (BMI), glycemic measures, and pregnancy-specific factors. However, only 38% of studies employed robust external validation, and small sample sizes limited generalizability in some cases. Risk of bias assessment revealed low overall bias, though analytical validation methods were often unclear or insufficient. ML models, particularly those integrating omics data, show strong potential for predicting T2D risk in women with prior GDM. However, heterogeneity in validation methods and limited external validation highlight the need for standardized reporting and larger, diverse cohorts to enhance clinical applicability. Future research should focus on developing reproducible, generalizable models to guide personalized prevention strategies.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

